Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T06:22:43.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T00:48:17.000Z thumbnail image
  5. Check
    30 days ago
    No Change Detected
  6. Check
    44 days ago
    Change Detected
    Summary
    The study has expanded to include 61 locations, and the website has been updated to Revision v2.10.0, replacing the previous Revision v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T15:23:25.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T09:11:00.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    A new study on the use of Ruxolitinib in addition to standard care for COVID-19 treatment has been published in Lancet Rheumatology, with an erratum issued in 2024.
    Difference
    0.1%
    Check dated 2024-07-05T18:00:29.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T15:38:58.000Z thumbnail image

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.